Literature DB >> 17720546

Motor and somatosensory evoked potentials in Autosomal Dominant Hereditary Spastic Paraparesis (ADHSP) linked to chromosome 2p, SPG4.

F Sartucci1, S Tovani, L Murri, L Sagliocco.   

Abstract

The aim of our study was to evaluate Motor Evoked Potentials (MEPs) and cortical excitability, using Transcranial Magnetic Stimulation (TMS) as well as short latency Somatosensory Evoked Potentials (SEPs) in Autosomal Dominant Hereditary Spastic Paraparesis (ADHSP) patients. MEPs were recorded from upper and lower limb muscles in 12 patients (7 m and 5f) affected by ADHSP with spastin mutation (SPG4). We measured: (i) motor threshold (MTh); (ii) total motor conduction time (TMCT); (iii) direct and indirect central motor conduction time (d-CMCT and i-CMCT) calculated by subtracting from the cortical latency those obtained on magnetic spinal stimulation (d-PMCT) and via the F-wave method (i-PMCT); (iv) MEP amplitude (MEP/Mmax ratio%) and (v) duration of the cortical silent period (CSP). Latency, amplitude and persistence of the F-wave obtained with electrical nerve stimulation were also considered; H reflex was also tested from lower extremities. SEPs were recorded from spine and scalp sites following median and posterior tibial nerve stimulation; conventional latency and amplitude measurements were performed. In a comparison with the control group, the MTh recording from lower limbs was significantly higher (67.5 +/- 7.7% versus 52.5 +/- 6.9%), MEPs were absent in one case and showed reduced amplitude in the remainders (22.9 +/- 12.6% versus 66.3 +/- 25.9% of M wave); TMCT resulted to be abnormal (36.5 +/- 3.9 ms versus 27.1 +/- 1.4 ms) and d-CMCT as well as i-CMCT were significantly prolonged (23.1 +/- 3.5 ms versus 13.8 +/- 1.3 ms; and 20.1 +/- 3.4 ms versus 10.6 +/- 1.3 ms, respectively). The CSP, which was normal from the hands, was significantly shortened from the legs and correlated with spasticity scoring (Ashworth scale). Cortical SEPs from lower limbs were abnormal in all cases, whereas SEPs by stimulation of median nerves were normal; F-wave parameters from upper limbs showed no abnormalities, whereas an increased persistence was detected from lower limbs; H reflex amplitudes resulted larger compared with controls. Moreover, shortening of the CSP, being correlated with the Ashworth scale, can be considered an electrophysiological marker of spasticity that seems to arise from impairment of the supraspinal or intracortical inhibitory pathways with an additional contribution of increased segmental motor neuron excitability. These data prove the existence of comparable neurophysiological abnormalities in ADHSP with spastin mutation (SPG4) when long ascending and descending pathways are involved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720546     DOI: 10.1016/j.brainresbull.2007.06.018

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  11 in total

1.  Clinical Spectrum of Hereditary Spastic Paraplegia in Children: A study of 74 cases.

Authors:  Roshan Koul; Fathiya M Al-Murshedi; Faisal M Al-Azri; Ranjit Mani; Rana A Abdelrahim; Vivek Koul; Amna M Alfutaisi
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

2.  Hand muscles corticomotor excitability in hereditary spastic paraparesis type 4.

Authors:  Federica Ginanneschi; Maria A Carluccio; Andrea Mignarri; Alessandra Tessa; Filippo M Santorelli; Alessandro Rossi; Antonio Federico; Maria T Dotti
Journal:  Neurol Sci       Date:  2014-03-20       Impact factor: 3.307

3.  Mechanisms of postural instability in hereditary spastic paraplegia.

Authors:  Jorik Nonnekes; Mark de Niet; Lars B Oude Nijhuis; Susanne T de Bot; Bart P C van de Warrenburg; Bastiaan R Bloem; Alexander C Geurts; Vivian Weerdesteyn
Journal:  J Neurol       Date:  2013-06-20       Impact factor: 4.849

4.  Somatosensory conduction pathway in spastic paraplegia type 5.

Authors:  Alessandra Vanotti; Lorenzo Nanetti; Davide Rossi Sebastiano; Elisa Visani; Dunja Duran; Daniela Di Bella; Elisa Sarto; Claudio Caccia; Valerio Leoni; Franco Taroni; Caterina Mariotti
Journal:  J Clin Neurol       Date:  2014-10-06       Impact factor: 3.077

5.  The Effect of Repetitive Transcranial Magnetic Stimulation on Motor Symptoms in Hereditary Spastic Paraplegia.

Authors:  J Antczak; J Pera; M Dąbroś; W Koźmiński; M Czyżycki; K Wężyk; M Dwojak; M Banach; A Slowik
Journal:  Neural Plast       Date:  2019-05-12       Impact factor: 3.599

6.  Motor Evoked Potentials in Hereditary Spastic Paraplegia-A Systematic Review.

Authors:  Sue-Faye Siow; Ruaridh Cameron Smail; Karl Ng; Kishore R Kumar; Carolyn M Sue
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

Review 7.  Lipid metabolic pathways converge in motor neuron degenerative diseases.

Authors:  Olivia J Rickman; Emma L Baple; Andrew H Crosby
Journal:  Brain       Date:  2020-04-01       Impact factor: 13.501

8.  Spinal direct current stimulation (tsDCS) in hereditary spastic paraplegias (HSP): A sham-controlled crossover study.

Authors:  Gianluca Ardolino; Tommaso Bocci; Martina Nigro; Maurizio Vergari; Alessio Di Fonzo; Sara Bonato; Filippo Cogiamanian; Francesca Cortese; Ilaria Cova; Sergio Barbieri; Alberto Priori
Journal:  J Spinal Cord Med       Date:  2018-12-03       Impact factor: 1.985

9.  Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP).

Authors:  Kathrin N Karle; Rebecca Schüle; Stephan Klebe; Susanne Otto; Christian Frischholz; Inga Liepelt-Scarfone; Ludger Schöls
Journal:  Orphanet J Rare Dis       Date:  2013-10-09       Impact factor: 4.123

10.  Clinical and Paraclinical Indicators of Motor System Impairment in Hereditary Spastic Paraplegia: A Pilot Study.

Authors:  Andrea Martinuzzi; Domenico Montanaro; Marinela Vavla; Gabriella Paparella; Paolo Bonanni; Olimpia Musumeci; Erika Brighina; Hana Hlavata; Giuseppe Rossi; Gayane Aghakhanyan; Nicola Martino; Alessandra Baratto; Maria Grazia D'Angelo; Francesca Peruch; Marianna Fantin; Alessia Arnoldi; Andrea Citterio; Chiara Vantaggiato; Vincenzo Rizzo; Antonio Toscano; Nereo Bresolin; Maria Teresa Bassi
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.